Prenatal diagnostic screening is a critical component in modern obstetrics for identifying chromosomal abnormalities in a fetus, which can lead to a variety of genetic disorders. Among the various techniques available, karyotyping and Fluorescence In Situ Hybridization (FISH) are prominent methods used to detect chromosomal abnormalities involving chromosomes 13, 18, 21, X, and Y. These particular chromosomes are commonly associated with genetic disorders such as Down syndrome (Trisomy 21), Patau syndrome (Trisomy 13), Edwards syndrome (Trisomy 18), and abnormalities related to the sex chromosomes (X and Y).
Karyotyping is a process that involves the examination of the chromosome set in a cell to identify and evaluate the size, shape, and number of chromosomes. It provides a comprehensive view of an individual’s chromosomes and can pinpoint abnormalities like extra chromosomes or missing chromosomes that are indicative of genetic disorders.
FISH, on the other hand, is a more targeted approach where fluorescent probes are used to visualize specific parts of chromosomes. This method is highly useful for identifying specific chromosomal abnormalities and is often used in conjunction with karyotyping for a more accurate diagnosis.
In the UAE, DNA Labs offers a prenatal diagnostic screening test that combines karyotyping and FISH to screen for abnormalities in chromosomes 13, 18, 21, X, and Y. This advanced screening test is available at a cost of 2700 AED. Conducted in a state-of-the-art facility, the test is designed to provide expectant parents with early and accurate information regarding their fetus's genetic health, enabling informed decisions throughout the pregnancy. DNA Labs UAE is committed to delivering precise and reliable results, employing the latest technologies and adhering to the highest standards of genetic testing.
The Alpha Thalassemia HBA1 – HBA2 Deletion-Duplication Analysis Test is a specialized diagnostic examination performed to detect genetic abnormalities associated with alpha thalassemia, a blood disorder reducing the production of hemoglobin. This test specifically looks for deletions or duplications in the HBA1 and HBA2 genes, which play critical roles in hemoglobin production. Identifying these genetic variations can help in diagnosing the condition, understanding its severity, and guiding treatment options.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis to ensure accurate diagnosis. The cost of the test is set at 2600 AED, reflecting the intricate technology and expertise required to perform this analysis. By opting for this test at DNA Labs UAE, patients can expect reliable results, contributing to better management of alpha thalassemia.
The Antithrombin III Antigen Test is a specialized diagnostic procedure aimed at measuring the levels of antithrombin III in the blood. Antithrombin III is a crucial protein that helps regulate blood clotting by inhibiting several enzymes in the coagulation system. Abnormal levels of this protein can indicate a risk of developing abnormal blood clots or may suggest an underlying condition affecting the clotting process.
This test is particularly important for individuals who have a family history of blood clotting disorders, have experienced unexplained thrombotic episodes, or are being evaluated for conditions that could affect coagulation balance. By assessing the antithrombin III antigen levels, healthcare providers can make informed decisions about the need for interventions or treatments to manage clotting disorders.
At DNA Labs UAE, the Antithrombin III Antigen Test is available for 2600 AED. DNA Labs UAE is known for its state-of-the-art facilities and adherence to high standards of diagnostic accuracy. By opting for this test at DNA Labs UAE, patients can expect reliable results that can play a significant role in the management and understanding of their coagulation status.
Immunophenotyping by Flow Cytometry Leukemia Lymphoma Diagnostic Panel, specifically for Chronic Lymphoproliferative Disorders T and B Cell Test, is a sophisticated diagnostic procedure available at DNA Labs UAE. This test, priced at 3510 AED, utilizes flow cytometry technology to analyze the characteristics of blood cells, particularly focusing on identifying and classifying chronic lymphoproliferative disorders (CLPDs) which include various types of leukemia and lymphoma. By assessing the expression of surface and intracellular molecules, this test helps in the accurate diagnosis and classification of T-cell and B-cell lymphoproliferative disorders. The detailed insights provided by this panel are crucial for determining the most effective treatment strategies for patients suffering from these conditions. DNA Labs UAE, by offering this advanced diagnostic test, plays a vital role in the early detection and management of leukemia and lymphoma, contributing significantly to patient care in the region.
The "Immunophenotyping by Flow Cytometry Leukemia Diagnostic Comprehensive Profile Any 6 Markers Test" is a sophisticated diagnostic procedure offered by DNA Labs UAE, designed to identify and analyze specific markers on the surface of cells in the blood or bone marrow. This test is crucial for the diagnosis and classification of various types of leukemia, a group of cancers that affect the blood and bone marrow. By examining up to six specific markers, healthcare professionals can determine the subtype of leukemia, which is essential for developing an effective treatment plan.
Flow cytometry, the technology used in this test, allows for the rapid analysis of multiple characteristics of single cells in a fluid mixture, making it a powerful tool in the diagnosis and monitoring of leukemia. This method involves staining cells with fluorescently labeled antibodies that bind to specific cell surface proteins (markers), and then passing these cells through a laser beam. The interaction of the laser light with the fluorescent molecules on the cells generates data that are analyzed to identify the presence and quantity of various cell types based on their specific markers.
The cost of the test at DNA Labs UAE is 3510 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology involved. Patients undergoing this test can expect a detailed report that aids in the precise diagnosis of leukemia, which is critical for tailoring treatment strategies to the individual's specific condition. This test represents a significant step forward in personalized medicine, offering hope for more effective and targeted leukemia treatments.
Medullary Thyroid Carcinoma (MTC) is a rare type of thyroid cancer that arises from the parafollicular cells (C cells) of the thyroid gland, which produce the hormone calcitonin. Early detection and treatment of MTC are crucial for improving patient outcomes. One of the key methods for detecting MTC involves identifying genetic mutations associated with the disease. The Medullary Thyroid Carcinoma Mutation Detection Test is a specialized diagnostic tool designed to identify specific genetic mutations in the RET proto-oncogene, which are known to increase the risk of developing MTC. This test is particularly important for individuals with a family history of MTC or for those diagnosed with thyroid nodules, as it helps in the early diagnosis and management of the condition.
Performed at DNA Labs UAE, the Medullary Thyroid Carcinoma Mutation Detection Test is conducted with state-of-the-art genetic testing technologies to ensure high sensitivity and specificity. The test cost is set at 3510 AED, reflecting the advanced nature of the technology and the expertise required to accurately interpret the results. By identifying the presence of mutations associated with MTC, this test plays a pivotal role in personalized patient care, allowing for tailored treatment strategies and improved surveillance for affected individuals and their families.
The Multiple Myeloma Comprehensive Profile Test is a specialized diagnostic evaluation designed to provide a detailed analysis of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. This test is crucial for the accurate diagnosis, prognosis, and monitoring of the disease, enabling healthcare providers to tailor the most effective treatment plans for their patients.
Performed at DNA Labs UAE, a leading facility in medical diagnostics, the test encompasses a range of assays and analyses to assess the genetic and molecular aspects of the cancer cells, as well as their impact on the patient's immune system and overall health. The comprehensive nature of the test allows for the detection of specific biomarkers and abnormalities associated with multiple myeloma, including but not limited to, chromosomal abnormalities, protein levels, and the presence of monoclonal proteins.
The cost of the Multiple Myeloma Comprehensive Profile Test is set at 3510 AED, reflecting the extensive resources, advanced technology, and expertise required to conduct this in-depth examination. By investing in this test, patients and their healthcare teams gain valuable insights into the specific characteristics of the myeloma, which is instrumental in developing a personalized treatment approach aimed at achieving the best possible outcomes.
The Oncopro EGFR Rapid Test is a cutting-edge diagnostic tool designed for the swift and accurate detection of mutations in the Epidermal Growth Factor Receptor (EGFR) gene. These mutations are crucial biomarkers in the diagnosis and treatment planning for various types of cancer, particularly non-small cell lung cancer (NSCLC). By identifying specific EGFR mutations, oncologists can tailor treatment strategies to target the genetic underpinnings of a patient's cancer, potentially improving outcomes and reducing the likelihood of adverse effects from less targeted therapies.
Performed at DNA Labs UAE, a leading facility in genetic testing and personalized medicine, the Oncopro EGFR Rapid Test leverages advanced molecular techniques to analyze a patient's DNA sample—usually obtained from a biopsy or a liquid biopsy—for the presence of EGFR mutations. This rapid test provides results faster than traditional genomic sequencing methods, enabling timely decision-making in clinical settings.
The cost of the Oncopro EGFR Rapid Test at DNA Labs UAE is set at 3510 AED. While the price may be considered high for some, the value it provides in guiding the precise treatment of cancer can be invaluable. Patients are encouraged to discuss with their healthcare providers whether this test is appropriate for their specific situation and to explore insurance coverage or financial assistance programs that may help offset the cost.
The "Oncopro KRAS Rapid Test" is a cutting-edge diagnostic tool designed for the rapid identification of mutations in the KRAS gene, which are often implicated in various types of cancer, including colorectal, lung, and pancreatic cancers. This test is especially crucial for tailoring cancer treatment strategies, as the presence of specific KRAS mutations can influence a patient's response to certain therapies. By quickly determining the KRAS mutation status, healthcare providers can make informed decisions about the most effective treatment plans for their patients, potentially improving outcomes.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities and commitment to precision medicine. The cost of the Oncopro KRAS Rapid Test is 3510 AED, reflecting the sophisticated technology and expertise involved in delivering accurate and timely results. This investment in personalized cancer diagnostics represents a significant step forward in optimizing patient care and enhancing the efficacy of targeted therapy regimens.
The Respiratory Comprehensive Panel Test is a sophisticated diagnostic tool designed to identify a wide array of respiratory pathogens, including viruses, bacteria, and fungi, that can cause respiratory infections. This test is particularly valuable in diagnosing the specific cause of respiratory ailments, ranging from common infections like the flu to more severe conditions such as pneumonia or COVID-19. By using advanced molecular techniques, the panel can detect multiple pathogens simultaneously, offering a thorough and efficient approach to diagnosing respiratory diseases.
Administered at DNA Labs UAE, a leading facility in medical diagnostics, the test ensures high accuracy and reliability. The cost of the Respiratory Comprehensive Panel Test is set at 3510 AED. This investment covers the comprehensive nature of the test, leveraging cutting-edge technology to provide detailed insights into the patient's respiratory health. Conducted in a state-of-the-art laboratory environment by skilled professionals, the test results are instrumental in guiding healthcare providers towards the most effective treatment plans, ultimately facilitating better patient outcomes.
